---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-25-000787"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2025-06-04T23:59:59+00:00"
generated_at: "2026-05-19T23:41:19.420026+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Immunic shareholders approve 7M share increase in equity plan, elect three Class II directors

## Summary
- Plan amendment increases authorized shares by 7,000,000 to 26,448,871; approved with 32,765,299 for, 10,731,124 against.
- Dr. Jörg Neermann, Tamar Howson, and Barclay Phillips elected as Class II directors until 2028.
- Baker Tilly US, LLP ratified as independent auditor for fiscal 2025 with 60,427,763 votes for.
- Quorum of 61,229,143 shares (63.9% of outstanding) present at June 4, 2025 annual meeting.

## SEC filing metadata
- accession: 0001193805-25-000787
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2025-06-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380525000787/0001193805-25-000787-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380525000787/e664589_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-25-000787
- JSON: https://secwatch.observer/filing/0001193805-25-000787.json
- Plain text: https://secwatch.observer/filing/0001193805-25-000787.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.